Effect of propranolol and depot lanreotide SR on postprandial and circadian portal haemodynamics in cirrhosis.

about

Variceal bleeding in cirrhotic patients: risk factors, evolution, treatment.Assessment of portal pressure in cirrhosis: how and when can we sedate?Circadian rhythm of fasting and postprandial portal blood flow in cirrhosis.

P2860

Q35713858-7576279A-AAFE-4F18-81C4-0B8DC59DA08C Q47939520-E1A603CB-4C80-47CC-9B84-F343470D5213 Q51496162-89E0F5CE-A4BB-444D-8ED8-0923879686AD

P2860

Effect of propranolol and depot lanreotide SR on postprandial and circadian portal haemodynamics in cirrhosis.

Item

http://www.wikidata.org/entity/Q44611976

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Effect of propranolol and depo ...... al haemodynamics in cirrhosis.

@en

Effect of propranolol and depo ...... al haemodynamics in cirrhosis.

@nl

type

Item

label

Effect of propranolol and depo ...... al haemodynamics in cirrhosis.

@en

Effect of propranolol and depo ...... al haemodynamics in cirrhosis.

@nl

prefLabel

Effect of propranolol and depo ...... al haemodynamics in cirrhosis.

@en

Effect of propranolol and depo ...... al haemodynamics in cirrhosis.

@nl

P1476

Effect of propranolol and depo ...... al haemodynamics in cirrhosis.

@en

P2093

B Stoffel-Wagner

http://www.w3.org/2001/XMLSchema#string

G Layer

http://www.w3.org/2001/XMLSchema#string

L Koch

http://www.w3.org/2001/XMLSchema#string

P Schiedermaier

http://www.w3.org/2001/XMLSchema#string

T Sauerbruch

http://www.w3.org/2001/XMLSchema#string

P2860

Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding.

A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis.

Randomised trial of octreotide for long term management of cirrhosis after variceal haemorrhage

Somatostatin receptor desensitization in NG108-15 cells. A consequence of receptor sequestration.

Pharmacokinetic and pharmacodynamic properties of a long-acting formulation of the new somatostatin analogue, lanreotide, in normal healthy volunteers.

Effects of different octreotide dosages on splanchnic hemodynamics and glucagon in patients with TIPS.

Effect of the somatostatin analogue lanreotide on meal-stimulated portal blood flow in patients with liver cirrhosis.

Effects of different octreotide dosages on splanchnic hemodynamics and glucagon in healthy volunteers.

Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension.

Effects of sustained-release lanreotide on hemodynamics in rats with portal vein stenosis.

P304

777-784

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2036.2003.01682.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9057776

http://www.w3.org/2001/XMLSchema#string

P698

14535870

http://www.w3.org/2001/XMLSchema#string

P921

hemodynamics

circadian rhythm

Effect of propranolol and depot lanreotide SR on postprandial and circadian portal haemodynamics in cirrhosis.

about

P2860

P2860

Effect of propranolol and depot lanreotide SR on postprandial and circadian portal haemodynamics in cirrhosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921